SMALL LYMPHOCYTIC LYMPHOMA VARIANT

Clinical trials for SMALL LYMPHOCYTIC LYMPHOMA VARIANT explained in plain language.

Never miss a new study

Get alerted when new SMALL LYMPHOCYTIC LYMPHOMA VARIANT trials appear

Sign up with your email to follow new studies for SMALL LYMPHOCYTIC LYMPHOMA VARIANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to help leukemia patients stop treatment

Disease control Recruiting now

This study is testing whether adding a drug called epcoritamab to standard treatment can help patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) achieve a deeper remission. The goal is to see if this combination can eliminate nearly all cancer ce…

Matched conditions: SMALL LYMPHOCYTIC LYMPHOMA VARIANT

Phase: PHASE2 • Sponsor: Zulfa Omer • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

SMALL LYMPHOCYTIC LYMPHOMA VARIANT

Get alerted when new SMALL LYMPHOCYTIC LYMPHOMA VARIANT trials appear

New drug combo aims to help leukemia patients stop treatment